Cantor Fitzgerald is monitoring the performance of Surgery Partners, a healthcare services provider in the US. Raymond James Financial and TD Cowen are also providing price targets and buy ratings.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald is monitoring the performance of Surgery Partners, a healthcare services provider in the US. Raymond James Financial and TD Cowen are also providing price targets and buy ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Surgery Partners
healthcare services company
-
Cantor Fitzgerald
American financial services company
-
Raymond James Financial
American Investment Bank and Financial Services Firm
- Citigroup reiterated a market perform rating, Bank of America restated an underperform rating, and Raymond James Financial started coverage for Omega Healthcare Investors, Inc.
- CIBC, Scotiabank, and Raymond James Financial issued rating updates, including upgrades and neutral ratings, on Interfor shares.
-
TD Cowen
American investment bank
Related events
- Cantor Fitzgerald raised price targets and reaffirmed ratings, while TD Cowen adjusted its ratings for Paylocity on August 7, 2026.
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.
- Multiple financial firms, including Raymond James, Wells Fargo, UBS, Cantor Fitzgerald, and KeyCorp, issued rating updates and target price changes on November 2, 2026.
- TD Cowen reaffirmed a buy rating while Cantor Fitzgerald downgraded monday.com Ltd. on October 6, 2026.
- Analyst firms Jefferies, TD Cowen, and Raymond James Financial provided rating updates for Black Diamond Therapeutics, alongside MarketBeat consensus data.